S
RARE icon

SignatureFD’s Ultragenyx Pharmaceutical RARE Stock Holding History

SignatureFD’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Buy
466
+232
+99% +$5.76K ﹤0.01% 2456
2026
Q1 		$4.9K Sell
234
-306
-57% -$6.89K ﹤0.01% 2786
2025
Q4 		$12.4K Sell
540
-6
-1% -$197 ﹤0.01% 2327
2025
Q3 		$16.4K Sell
546
-113
-17% -$3.39K ﹤0.01% 2202
2025
Q2 		$24K Buy
659
+80
+14% +$2.88K ﹤0.01% 1972
2025
Q1 		$21K Sell
579
-256
-31% -$10.7K ﹤0.01% 2034
2024
Q4 		$35.1K Sell
835
-40
-5% -$1.98K ﹤0.01% 1758
2024
Q3 		$48.6K Buy
875
+112
+15% +$5.71K ﹤0.01% 1592
2024
Q2 		$31.4K Buy
763
+24
+3% +$1.02K ﹤0.01% 1750
2024
Q1 		$34.5K Buy
739
+62
+9% +$2.92K ﹤0.01% 1737
2023
Q4 		$32.4K Sell
677
-240
-26% -$9.3K ﹤0.01% 1682
2023
Q3 		$32.7K Sell
917
-104
-10% -$4.12K ﹤0.01% 1611
2023
Q2 		$47.1K Buy
1,021
+305
+43% +$14.1K ﹤0.01% 1468
2023
Q1 		$28.7K Sell
716
-746
-51% -$32K ﹤0.01% 1673
2022
Q4 		$67.7K Buy
1,462
+862
+144% +$33.9K ﹤0.01% 1199
2022
Q3 		$25K Buy
600
+361
+151% +$18.6K ﹤0.01% 1639
2022
Q2 		$14K Buy
239
+98
+70% +$6.03K ﹤0.01% 1959
2022
Q1 		$10K Buy
141
+47
+50% +$3.27K ﹤0.01% 2165
2021
Q4 		$8K Buy
94
+67
+248% +$5.45K ﹤0.01% 2229
2021
Q3 		$2K Buy
27
+21
+350% +$1.9K ﹤0.01% 2695
2021
Q2 		$1K Sell
6
-11
-65% -$1.15K ﹤0.01% 2802
2021
Q1 		$2K Sell
17
-5
-23% -$681 ﹤0.01% 2519
2020
Q4 		$3K Buy
22
+16
+267% +$1.9K ﹤0.01% 2165
2020
Q3 		$0 Buy
+6
New +$497 ﹤0.01% 2727
2018
Q4 		– Sell
-1
Closed – – 2042
2018
Q3 		$0 Hold
1
– – ﹤0.01% 1982
2018
Q2 		$0 Hold
1
– – ﹤0.01% 1964
2018
Q1 		$0 Buy
+1
New +$50 ﹤0.01% 1763

Other funds holding RARE

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

SignatureFD's RARE Position: Q2 2026 in Review

SignatureFD increased its Ultragenyx Pharmaceutical (RARE) stake by 99% in Q2 2026, buying an estimated $5.76K and bringing the position to 466 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

SignatureFD first reported a position in RARE in Q1 2018 and has held it in 27 quarters since. The position peaked at $67.7K in Q4 2022. 39 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • SignatureFD held 466 shares of Ultragenyx Pharmaceutical worth $15.6K as of Q2 2026.
  • SignatureFD bought 232 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $5.76K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2456 holding.
  • SignatureFD first reported a position in Ultragenyx Pharmaceutical in Q1 2018 and has held it in 27 quarters since.
  • SignatureFD's Ultragenyx Pharmaceutical position peaked at $67.7K in Q4 2022.
  • 39 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.